Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Aradhye

Javraj Dilipbhai Aradhye, Baroda IN

Patent application numberDescriptionPublished
20120040897NOVEL DERIVATIVES OF ACYL CYANOPYRROLIDINES - A compound of formula (I) or a tautomeric form, regioisomer, stereoisomer, solvate, N-oxide or pharmaceutically acceptable salts thereof; wherein ‘a’—is selected from the group consisting of substituted or unsubstituted heterocycloalkyl ring and substituted or unsubstituted carbohydrate moiety y is a member selected from —O—, —CO—, —S02-, aminoalkyl or formula (II) wherein, R02-16-2012

Jayraj D. Aradhye, Baroda IN

Patent application numberDescriptionPublished
20090264469NOVEL DICARBOXYLIC ACID DERIVATIVES - The present patent application concerns new compounds of formula (I): displaying agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents.10-22-2009

Jayraj Dilipbhal Aradhye, Baroda IN

Patent application numberDescriptionPublished
20100249187NOVEL DICARBOXYLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS - The present invention relates to new compounds of formula (I) possessing agonistic activity at sphingosine-1-phosphate (S1P) receptors, their process of preparation and their use as immunosuppressive agents. The invention is also directed to pharmaceutical compositions containing these compounds and use of these compounds for treatment/prevention of immune mediated diseases and conditions or inflammatory diseases and conditions.09-30-2010

Shreeram Aradhye, West Orange, NJ US

Patent application numberDescriptionPublished
20080206240Antilymphocyte Antibody Induction - An immunosuppressive treatment combining a S1 P receptor modulator, one or more immunosuppressive drug(s) and an antilymphocyte antibody in the course of the treatment of a transplant recipient prolongs the survival of a transplant allograft.08-28-2008

Shreeram Aradhye, Holzkirchen DE

Patent application numberDescriptionPublished
20110124605Use of an S1P Receptor Agonist - The present invention relates to new uses of S1P receptor modulator or agonist such as fingolimod, for reducing or delaying the progression of cerebral atrophy.05-26-2011